Nickname
bschnittker
Website
Author Introduce

The course “Training for the accreditation of the professionals of the Endoscopic Units of the Colorectal Cancer Population Screening Program” has started. The first session of the course, organized by the technical office of screening of the Catalan Institute of Oncology, which covers the entire territory of the metropolitan area of Barcelona, was held on […]

Read More

The team of the Cancer Screening Unit together with researchers from the Biomarkers and Susceptibility Unit of the Institut Català d’Oncologia have demonstrated the benefit of participating in population screening for colorectal cancer with the fecal occult blood test in l’Hospitalet de Llobregat and l’Alt Penedès. This test allows to analyze if there is a […]

Read More

According to a study prepared by researchers from the Cancer Screening Unit of the ICO l’Hospitalet and the EPIBELL Program (IDIBELL), in the period 2017-2018, out of a total of 643 pharmacies affiliated to the Official College of Pharmacists, 528 were adhered to the Program, a figure that corresponds to 85.4% of the total. Accessibility […]

Read More

Tumors missed by screening tests are known as interval cancers and are diagnosed after a negative screening episode result but before the next cancer screening program invitation. The Cancer Screening Unit team together with researchers from the Biomarkers and Susceptibility Unit of the Institut Català d’Oncologia have reviewed the current literature on interval colorectal cancer […]

Read More

The ICO Advisory Committee has been created with the aim of providing the General Directorate with permanent advice of proven solvency and sufficient specialization in the care of oncology patients and all users served by ICO in its different areas (prevention, care, research, and teaching). The Committee is made up of 20 professionals from different […]

Read More

After the stoppage generated by Covidien-19 in March, the colorectal cancer screening program resumes its activity. The program, with its 20-year history, has detected more than 13,800 precancerous lesions and more than 1,000 cancers, most of them in early stages. Therefore, having demonstrated its effectiveness and convinced of the importance of prevention, the program has […]

Read More